After disease progression on osimertinib and other therapies, the patient began amivantamab monotherapy. Within six weeks, his lung tumor shrank by over 30 percent. By six months, imaging ...

The decision was welcomed by patient organisation EGFR Positive, whose co-chair – Jenny Abbott – said: “Osimertinib is an important treatment option for these patients, with the potential to ...

and AbbVie is looking specifically at this group in a phase 1 study that is looking at the combination of Teliso-V and AstraZeneca's EGFR inhibitor Tagrisso (osimertinib), to see if the ADC can ...

Russian drugmaker Axelpharm has managed to lift the ban on the launch of osimertinib - a drug, which is used in the treatment of lung cancer - in the domestic market, reports The Pharma Letter’s local ...

Although using osimertinib (Tagrisso) remains a frontline stalwart, data presented during ELCC 2025 can spur additional conversations with clinicians and their patients regarding optional approaches ...

President Donald J. Trump has signaled that lowering the costs of prescription drugs will be a priority for his second term. President Donald J. Trump has signaled that lowering the costs of ...

Lung cancer is one of the most frequently diagnosed cancers and the leading cause of cancer-related deaths worldwide with an estimated 2 million new cases and 1·76 million deaths per year. Substantial ...